These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34923938)

  • 21. Inhibition of thioredoxin reductase (TrxR) triggers oxidative stress-induced apoptosis in filarial nematode Setaria cervi channelized through ASK-1-p38 mediated caspase activation.
    Joardar N; Sen A; Rath J; Babu SPS
    Mol Biochem Parasitol; 2021 Mar; 242():111364. PubMed ID: 33639230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sanguinarine as a new chemical entity of thioredoxin reductase inhibitor to elicit oxidative stress and promote tumor cell apoptosis.
    Yao J; Duan D; Song ZL; Zhang J; Fang J
    Free Radic Biol Med; 2020 May; 152():659-667. PubMed ID: 31931095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances in the development of thioredoxin reductase inhibitors as anticancer agents.
    Liu Y; Li Y; Yu S; Zhao G
    Curr Drug Targets; 2012 Oct; 13(11):1432-44. PubMed ID: 22876886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of novel organoarsenicals as robust thioredoxin reductase inhibitors for oxidative stress mediated cancer therapy.
    She W; Shi X; Liu T; Liu Y; Liu Y
    Biochem Pharmacol; 2023 Dec; 218():115908. PubMed ID: 37931662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Auranofin, an inhibitor of thioredoxin reductase, induces apoptosis in hepatocellular carcinoma Hep3B cells by generation of reactive oxygen species.
    Hwang-Bo H; Jeong JW; Han MH; Park C; Hong SH; Kim GY; Moon SK; Cheong J; Kim WJ; Yoo YH; Choi YH
    Gen Physiol Biophys; 2017 Apr; 36(2):117-128. PubMed ID: 28218611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of both thioredoxin reductase and glutathione reductase may contribute to the anticancer mechanism of TH-302.
    Li S; Zhang J; Li J; Chen D; Matteucci M; Curd J; Duan JX
    Biol Trace Elem Res; 2010 Sep; 136(3):294-301. PubMed ID: 19838642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Understanding the survival mechanisms of Deinococcus radiodurans against oxidative stress by targeting thioredoxin reductase redox system.
    Maqbool I; Ponniresan VK; Govindasamy K; Prasad NR
    Arch Microbiol; 2020 Nov; 202(9):2355-2366. PubMed ID: 31570971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Motexafin gadolinium, a tumor-selective drug targeting thioredoxin reductase and ribonucleotide reductase.
    Hashemy SI; Ungerstedt JS; Zahedi Avval F; Holmgren A
    J Biol Chem; 2006 Apr; 281(16):10691-7. PubMed ID: 16481328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2a, a novel curcumin analog, sensitizes cisplatin-resistant A549 cells to cisplatin by inhibiting thioredoxin reductase concomitant oxidative stress damage.
    Zhou B; Huang J; Zuo Y; Li B; Guo Q; Cui B; Shao W; Du J; Bu X
    Eur J Pharmacol; 2013 May; 707(1-3):130-9. PubMed ID: 23524096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of thioredoxin reductase and glutathione reductase in plumbagin-induced, reactive oxygen species-mediated apoptosis in cancer cell lines.
    Hwang GH; Ryu JM; Jeon YJ; Choi J; Han HJ; Lee YM; Lee S; Bae JS; Jung JW; Chang W; Kim LK; Jee JG; Lee MY
    Eur J Pharmacol; 2015 Oct; 765():384-93. PubMed ID: 26341012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cross-talk between two antioxidants, thioredoxin reductase and heme oxygenase-1, and therapeutic implications for multiple myeloma.
    Raninga PV; Di Trapani G; Vuckovic S; Tonissen KF
    Redox Biol; 2016 Aug; 8():175-85. PubMed ID: 26795735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The thioredoxin antioxidant system.
    Lu J; Holmgren A
    Free Radic Biol Med; 2014 Jan; 66():75-87. PubMed ID: 23899494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of thioredoxin reductase by natural anticancer candidate β-lapachone accounts for triggering redox activation-mediated HL-60 cell apoptosis.
    Zhang J; Xu Q; Ma D
    Free Radic Biol Med; 2022 Feb; 180():244-252. PubMed ID: 35091063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactions of nitroaromatic compounds with the mammalian selenoprotein thioredoxin reductase and the relation to induction of apoptosis in human cancer cells.
    Cenas N; Prast S; Nivinskas H; Sarlauskas J; Arnér ES
    J Biol Chem; 2006 Mar; 281(9):5593-603. PubMed ID: 16354662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural Modification of Aminophenylarsenoxides Generates Candidates for Leukemia Treatment
    Song ZL; Zhang J; Xu Q; Shi D; Yao X; Fang J
    J Med Chem; 2021 Nov; 64(21):16132-16146. PubMed ID: 34704769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activity assays of mammalian thioredoxin and thioredoxin reductase: fluorescent disulfide substrates, mechanisms, and use with tissue samples.
    Montano SJ; Lu J; Gustafsson TN; Holmgren A
    Anal Biochem; 2014 Mar; 449():139-46. PubMed ID: 24374250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase.
    Gandin V; Fernandes AP; Rigobello MP; Dani B; Sorrentino F; Tisato F; Björnstedt M; Bindoli A; Sturaro A; Rella R; Marzano C
    Biochem Pharmacol; 2010 Jan; 79(2):90-101. PubMed ID: 19665452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of thioredoxin reductase by mansonone F analogues: Implications for anticancer activity.
    Liu Z; Huang SL; Li MM; Huang ZS; Lee KS; Gu LQ
    Chem Biol Interact; 2009 Jan; 177(1):48-57. PubMed ID: 18822278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Susceptibility of the antioxidant selenoenyzmes thioredoxin reductase and glutathione peroxidase to alkylation-mediated inhibition by anticancer acylfulvenes.
    Liu X; Pietsch KE; Sturla SJ
    Chem Res Toxicol; 2011 May; 24(5):726-36. PubMed ID: 21443269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of Mammalian Thioredoxin Reductase Inhibitors.
    Arnér ESJ
    Handb Exp Pharmacol; 2021; 264():289-309. PubMed ID: 32767140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.